Director/PDMR Shareholding

RNS Number : 2579C
GlaxoSmithKline PLC
27 April 2012
 



 

 

 

 

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

I give below details of changes in interests in  American Depositary Shares (ADSs) of GlaxoSmithKline plc in respect of the under-mentioned Person Discharging Managerial Responsibility on 26 April 2012:-

 

Mr W C Louv

 Exercise of option over 2,684 ADSs, granted on 3 December 2002 under the GlaxoSmithKline Share Option Plan at a price of $37.25 per ADS, and sale of 2,684 ADSs at a price of $46.132 per ADS.

 

Exercise of option over 22,316 ADSs, granted on 3 December 2002 under the GlaxoSmithKline Share Option Plan at a price of $37.25 per ADS, and sale of 22,316 ADSs at a price of $46.123 per ADS.

 

 



The Company and the above-mentioned person were advised of these transactions on 27 April 2012.

 

This notification relates to transactions notified in accordance with Disclosure Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

 

27 April 2012

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFDLFLLZFZBBE

Companies

GSK (GSK)
UK 100